Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1693
| Despition | CDK1 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 85.0% (SDS-PAGE) |
| Form | Sterile filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1232 | GPCR GPR15 Blocking Peptide (AC1232) | 250 µg | inquiry |
| ACPP-1652 | Human WWC1 Protein (AC1652) | 5 µg | inquiry |
| ACPP-1377 | Human KCNMB3 Protein (AC1377) | 5 µg | inquiry |
| ACPP-1160 | Recombinant Human GPCR GPR20 Protein (Fc Tag) (AC1160) | 50 µg | inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
| ACPP-1011 | Recombinant Human FGF1 Protein (AC1011) | 50 µg | inquiry |
| ACPP-1088 | Synthetic Exosome Human CD24 Protein (AC1088) | 50 µg | inquiry |
| ACPP-1091 | BMP11 Blocking Peptide (AC1091) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.